E0110 (Seradex-LA 6 mg-19 mg)
Generic Name: brompheniramine/carbetapentane/phenylephrine
Pill imprint E0110 has been identified as Seradex-LA 6 mg-19 mg.
Seradex is used in the treatment of cold symptoms; cough and nasal congestion; allergic rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Seradex 6 mg-19 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- brompheniramine/carbetapentane/phenylephrine
- Imprint:
- E0110
- Strength:
- 6 mg-19 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Allegis Pharmaceuticals
- National Drug Code (NDC):
- 28595-0110
More about Seradex (brompheniramine / carbetapentane / phenylephrine)
- Side Effects
- During Pregnancy
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Consumer resources
Other brands: BetaTan, Vazotan, V-COF
Professional resources
Other Formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
